Sorry Twinvest, but I think you're just continuing with the same old excuses we've been hearing for the last 2 years.
I think it's less about investing in this industry sector and more about management not living up to shareholder expectations.
I give them the benefit of the doubt that they perform well in certain areas, such as bio-tech expertise, but management roles include shareholder relations and value growth.
They're not good at this.
Sorry Twinvest, but I think you're just continuing with the same...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.36M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.1¢ | 2.0¢ | $33.18K | 1.658M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 2717347 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 723484 | 6 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| ADO (ASX) Chart |